Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   


amyloid-beta4 - fischer1 - alzheimer sufferer1 - chronic sleep deprivation1 - substantia nigra7 - carotid ultrasound1 - degeneration theory1 - mind diet1 - management of delirium1 - american psychiatric association3 - quit smoking1 - pdd3 - cognitive deficits1 - α-synuclein protein2 - cjd2 - motor symptoms1 - ad prognosis1 - mentally weak1 - deficiency of thiamine1 - amentia2 - irreversible dementia syndrome1 - trigger for alzheimer's1 - permanent brain damage1 - myxoedema1 - risperidone2 - preventing alzheimer's1 - plaque in alzheimer's disease1 - hyperammonemia1 - cerebrovascular disease1 - memory robbing disease1 -